Daejeon, South Korea

Zi-Ho Yeom

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2011.


% Patents Active = 100.0


Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Zi-Ho Yeom

Introduction

Zi-Ho Yeom is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Dipeptidyl Peptidase-IV (DPP-IV). His work is crucial in the advancement of treatments for various medical conditions.

Latest Patents

Zi-Ho Yeom holds a patent for "Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent." This patent includes novel compounds that exhibit good inhibitory activity against DPP-IV. The compounds are characterized by specific chemical formulas, which include various substituted or unsubstituted structures. The methods of preparing these compounds and their pharmaceutical applications are also disclosed in the patent.

Career Highlights

Zi-Ho Yeom is currently employed at LG Life Sciences, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that can improve patient outcomes. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Zi-Ho Yeom has collaborated with esteemed colleagues such as Chang-Seok Lee and Jong Sung Koh. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Zi-Ho Yeom's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…